194 related articles for article (PubMed ID: 24561415)
1. Hydralazine associated pauci-immune glomerulonephritis.
Suneja M; Baiswar S; Vogelgesang SA
J Clin Rheumatol; 2014 Mar; 20(2):99-102. PubMed ID: 24561415
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
Dobre M; Wish J; Negrea L
Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
[TBL] [Abstract][Full Text] [Related]
4. Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Al-Abdouh A; Siyal AM; Seid H; Bekele A; Garcia P
J Med Case Rep; 2020 Apr; 14(1):47. PubMed ID: 32290867
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
Kumar B; Strouse J; Swee M; Lenert P; Suneja M
Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis.
Acharya I; Weisman DS; Smith LW; Arend LJ
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429646
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
Rasla S; El Meligy A; Cucu DF
R I Med J (2013); 2016 Nov; 99(11):41-43. PubMed ID: 27801920
[TBL] [Abstract][Full Text] [Related]
8. An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.
Bomback AS
Clin J Am Soc Nephrol; 2017 May; 12(5):836-838. PubMed ID: 28274994
[No Abstract] [Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
[TBL] [Abstract][Full Text] [Related]
10. Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis.
Zuckerman R; Patel M; Costanzo EJ; Dounis H; Haj RA; Seyedali S; Asif A
J Bras Nefrol; 2018; 40(2):193-197. PubMed ID: 29738027
[TBL] [Abstract][Full Text] [Related]
11. Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Paley MA; Edrees F; Kudose S; Gaut JP; Ranganathan P; Vijayan A
Saudi J Kidney Dis Transpl; 2019; 30(1):226-230. PubMed ID: 30804286
[TBL] [Abstract][Full Text] [Related]
12. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
[TBL] [Abstract][Full Text] [Related]
13. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
14. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Marina VP; Malhotra D; Kaw D
Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.
Doughem K; Battisha A; Sheikh O; Konduru L; Madoukh B; Al-Sadawi M; Shaikh S
Curr Cardiol Rev; 2021; 17(2):182-187. PubMed ID: 32418528
[TBL] [Abstract][Full Text] [Related]
16. Overlapping drug-induced vasculitis, ANCA-associated vasculitis, and lupus nephritis caused by low-dose hydralazine.
Bhatnagar M; Agaronov A; Sarkisyan E; Sotoudeh Deilamy I; Pepito D; Akhondi H
Int J Rheum Dis; 2023 Nov; 26(11):2272-2277. PubMed ID: 37452463
[TBL] [Abstract][Full Text] [Related]
17. Pauci-immune necrotizing glomerulonephritis.
Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
[TBL] [Abstract][Full Text] [Related]
18. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
Short AK; Lockwood CM
QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
[TBL] [Abstract][Full Text] [Related]
19. Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome.
Aeddula NR; Pathireddy S; Ansari A; Juran PJ
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413463
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine and lupus nephritis.
Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
